HealthAugust 12, 2026

95% of prior automation denials get reversed: Why prior authorization automation starts with better data

Key Takeaways

  • Prior authorization denials are reversed on appeal at rates approaching 95%, suggesting the clinical evidence often exists but is not consistently surfaced, interpreted, or applied during initial review.
  • CMS-0057-F standardizes how prior authorization data moves between organizations, but organizations must still ensure that data is accurate, complete, and semantically aligned.
  • Prior authorization breaks down when clinical evidence is fragmented across records, represented in different code systems, interpreted inconsistently across stakeholders, or used to train automation without proper governance.
  • Organizations that invest in terminology management, value set management, semantic crosswalks, and clinical definition governance will be best positioned for electronic and AI-enabled prior authorization.

Denied prior authorization requests are overturned on appeal at strikingly high rates. Here is why the fix is better data, not just faster APIs.

Some analyses have found that prior authorization denials are overturned on appeal at rates approaching 95%. When decisions are overturned that frequently, it raises an important question: are these denials primarily about medical necessity, or are they often the result of how clinical information is captured, exchanged, and interpreted during the review process?

In many cases, the evidence needed to support approval already exists. The challenge is that it may be buried within clinical documentation, scattered across multiple systems, represented in different code sets, or difficult to translate into the format required for authorization decisions.

Why prior authorization automation requires more than system interoperability

Historically, reviewers often relied on PDFs, scanned documentation, clinical notes, portals, faxed records, or manual chart review to determine whether authorization criteria had been met. Electronic prior authorization (ePA) is helping the industry move beyond those manual processes by enabling more structured exchange of clinical data. However, digitizing information does not automatically make it usable. Clinical evidence that was once trapped in a note may now be exchanged electronically, but it can still be represented in terminologies that different stakeholders interpret differently.

The healthcare industry has invested heavily in interoperability, APIs, and automation. Those investments are necessary. But interoperability alone cannot solve problems caused by incomplete documentation, inconsistent terminology, poorly governed clinical definitions, or disconnected coding systems. As prior authorization becomes increasingly electronic and AI-driven, data quality becomes a foundational requirement for success

The Prior Authorization Final Rule CMS-0057-F raises the stakes for data quality

With the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) scheduled to take effect on January 1, 2027, impacted payers have less than five months to prepare for a new era of electronic prior authorization.

The regulation requires impacted organizations to support electronic prior authorization through FHIR-based APIs, including Coverage Requirements Discovery (CRD), Documentation Templates and Rules (DTR), and Prior Authorization Support (PAS). The goal is clear: reduce administrative burden, increase transparency, and accelerate access to care.

Importantly, the FHIR framework does support the exchange of required diagnoses, procedures, and other authorization-related data elements. The challenge is that those data elements may be represented in either clinical terminologies such as SNOMED CT, LOINC, and RxNorm or administrative code systems such as ICD-10-CM, CPT, and HCPCS. While the data can move successfully between systems, organizations still need a way to ensure that everyone interprets that information consistently.

This distinction is critical.

CMS-0057-F addresses how information moves. It does not guarantee that the information is complete, clinically meaningful, semantically aligned, or consistently governed once it arrives. If missing diagnoses, coding inconsistencies, incomplete documentation, or terminology mismatches contribute to denials today, simply automating those workflows may accelerate the problem rather than eliminate it.

The transition to electronic prior authorization therefore creates a dual requirement: organizations must focus on both interoperability and data quality.

The future of prior authorization will not be determined by how quickly data moves between systems. It will be determined by whether those systems can consistently understand and act on the clinical meaning of that data.

Four data quality challenges that continue to break prior authorization automation

 1. The evidence is scattered across the record  

Prior authorization decisions often require information drawn from diagnoses, medications, procedures, laboratory tests, observations, and clinician documentation. Determining whether medical necessity criteria have been met depends on identifying the right evidence across an increasingly complex patient record.

The challenge is not simply locating information. It is ensuring organizations consistently know which information should be considered relevant to a particular authorization decision.

This is where clinical definitions become essential.

Organizations need a consistent way to define which data elements are relevant to a particular authorization decision. Which diagnoses should be considered? Which laboratory results matter? Which procedures, medications, or historical conditions help establish clinical appropriateness? Without clearly governed definitions, assembling the complete clinical picture becomes difficult and often requires manual intervention.

Managing those definitions at scale requires more than static spreadsheets and one-time policy reviews. Healthcare organizations need the ability to build, maintain, govern, and share collections of clinically related concepts across multiple vocabularies.

This is where value set management plays a critical role. Well-governed value sets help ensure that prior authorization criteria remain accurate, consistent, and up to date as coding systems evolve. More importantly, they help organizations consistently identify the clinical evidence needed to support authorization decisions, reducing the likelihood that relevant information is overlooked during review.

 2. Providers and payers speak different code languages  

One of the most persistent challenges in prior authorization is that providers and payers frequently represent the same clinical concepts using different terminologies.

Providers commonly document care using standards such as SNOMED CT, LOINC, RxNorm, and ICD-10. Administrative workflows and reimbursement processes often rely on CPT and HCPCS code sets. While these terminologies may represent the same clinical intent, they are not inherently interchangeable.

As electronic prior authorization expands, information that was once buried in narrative notes can now be exchanged as structured clinical data. However, this introduces a new challenge. The issue is no longer simply that data cannot be accessed. The issue is whether receiving systems can understand and appropriately use information documented in a different clinical language.

A laboratory finding captured in LOINC may be part of the evidence needed to satisfy an authorization policy written against CPT-based criteria. The evidence exists, but connecting those concepts requires more than technical interoperability. It requires semantic interoperability.

This is where prior authorization crosswalks and terminology relationships become critical. Crosswalks help translate clinical intent across disparate coding systems, while supportive and comparable code relationships help ensure relevant evidence is not missed simply because it was documented differently.

Example: A lab finding documented in LOINC 24331-1 has to be understood by a policy written against CPT 80061. The evidence exists in one language and the decision runs in another. Crosswalks translate the meaning, so the request clears instead of stalling.

As prior authorization becomes increasingly automated, these semantic relationships become essential. Automation can only succeed if systems are capable of recognizing when different codes represent the same or similar clinical intent.

 3. No single stakeholder can fix it alone  

Prior authorization is often framed as a payer problem. In reality, it is an ecosystem challenge involving providers, payers, EHR vendors, delegated review organizations, interoperability platforms, and technology partners.

Payers can digitize authorization requirements, but providers depend on EHR capabilities to surface those requirements at the point of care. Providers can improve documentation practices, but supporting technologies must be able to capture, structure, and exchange the right information in ways that are usable downstream.

Delays and denials frequently result from breakdowns between systems rather than failures within any single organization. Different participants may possess the necessary information but interpret, organize, or exchange it differently.

Patients ultimately bear the consequences through delayed treatment. Providers face increased administrative burden. Payers absorb the cost of manual reviews, rework, and appeals. Improving prior authorization therefore requires a shared semantic foundation that enables every participant to operate from the same understanding of clinical intent.

 4. AI inherits whatever data you feed it  

The growing use of AI in prior authorization creates significant opportunities to reduce manual effort and improve efficiency. Given the volume and complexity of authorization requests, automation will likely play an increasingly important role in future workflows.

AI does not solve data quality problems. It inherits and scales them.

Feed a model incomplete documentation, outdated code mappings, weak terminology relationships, or poorly governed clinical definitions, and it will learn those inconsistencies and reproduce them at scale. Poor-quality data can also introduce bias and reduce confidence in future decision-making.

Organizations preparing for AI-enabled prior authorization should focus first on strengthening terminology management, value set governance, clinical definition management, and ensuring semantic consistency across systems. AI readiness begins with data readiness.

When prior authorization lacks quality data, patients pay the price  

Prior authorization is often discussed in terms of workflows, regulations, and technology. Yet its impact is ultimately measured through patient and provider experiences.

Patients wait longer for treatment when requests are delayed, denied, and appealed. Providers spend valuable time collecting documentation and navigating administrative requirements rather than caring for patients. Administrative teams manage growing workloads, while payers absorb the costs associated with repeated reviews and appeals.

These pressures contribute to provider burnout, rising administrative expenses, and reduced trust across the healthcare ecosystem. Improving prior authorization requires more than faster workflows. It requires greater confidence that the information being exchanged accurately reflects the patient's clinical needs.

The next layer of prior authorization automation is semantic, not just connected systems

The healthcare industry has spent the last decade building the infrastructure needed to exchange information electronically. CMS-0057-F accelerates that progress by requiring the pipes for electronic prior authorization.

But the longer-term opportunity extends beyond connectivity.

The regulation also opens the door to greater automation through technologies such as Clinical Quality Language (CQL), which can support more automated evaluation of medical necessity criteria. These future capabilities depend on standardized FHIR data elements, governed value sets, and consistent terminology foundations. Organizations that implement electronic prior authorization thoughtfully today will be better positioned to support automated prior authorization workflows tomorrow.

The next phase of modernization is semantic. It is about ensuring that clinical intent remains intact as information moves between provider systems, payer platforms, authorization workflows, and AI-enabled decision support tools.

Terminology management, value set management, semantic crosswalks, supportive code relationships, and clinical definition governance provide that foundation. Together, these capabilities help organizations answer a critical question: Have we identified all of the clinical evidence necessary to make the right decision?

Value set management enables organizations to define and maintain authorization criteria consistently. Prior authorization crosswalks help translate clinical intent across disparate terminologies. Supportive and comparable code relationships help ensure relevant evidence is not missed simply because it was documented differently. Terminology management provides the governance necessary to keep those relationships accurate over time.

Your prior authorization automation is only as good as your data

The denial-reversal data offers an important lesson. If most denied requests are ultimately approved, healthcare may not be facing a medical necessity problem as much as a data quality problem. In many cases, the evidence exists. The future of prior authorization will not be determined by how quickly data moves between systems. It will be determined by whether those systems can consistently understand and act on the clinical meaning of that data.

Organizations that invest in data quality today will be best positioned to reduce denials, support automation, scale AI initiatives, and accelerate access to care.

Learn how Wolters Kluwer, Health Language helps healthcare organizations strengthen data quality through terminology management, value set management, semantic crosswalks, and clinical definition governance to support the future of prior authorization.

Explore Data Quality Solutions for Prior Authorization
Shoba Phansalkar
Shobha Phansalkar, PhD, FAMIA, is the VP of Client Solutions and Innovation at Wolters Kluwer, Health Language.

Shobha Phansalkar, PhD, FAMIA, is the Vice President of Client Solutions and Innovation for Wolters Kluwer, Health Language, where she leverages her extensive expertise in medical informatics to drive impactful solutions that address challenges in semantic interoperability and enhance healthcare data quality.

Back To Top